Coursera vs Universal Technical Institute
Add, change or remove companies; up to four.
The short version
- Universal Technical Institute is the larger business, with $836M of revenue in fiscal 2025 against $758M for Coursera.
- Universal Technical Institute grew revenue faster (14.1%, against 9.0%).
- Universal Technical Institute kept more of each dollar of sales as operating profit (10.0% operating margin, against β10.2%).
- Coursera turned more of its sales into free cash flow (14.2% FCF margin, against 6.6%).
| Latest fiscal year | COUR Β· FY25 | UTI Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $1.2B | $1.2B |
| Revenue | $758M | $836M |
| Free cash flow | $107M | $55.4M |
| Net income | β$51.0M | $63.0M |
| Growth | ||
| Revenue growth | 9.0% | 14.1% |
| 5-year growth | 20.9% | 22.7% |
| Share count change | 4.1% | 9.4% |
| Profitability | ||
| Gross margin | 54.6% | β |
| Operating margin | β10.2% | 10.0% |
| Net margin | β6.7% | 7.5% |
| FCF margin | 14.2% | 6.6% |
| Return on capital | β | 24.0% |
| Return on equity | β8.3% | 21.4% |
| Balance sheet | ||
| Net debt | β$793M | β$36.5M |
| Net debt / EBITDA | β | β0.3x |
| Dividends and buybacks | $0.0M | $0.0M |
| Valuation & quality | ||
| P/E | β | 35.8x |
| Piotroski F-score | 5 | 6 |
Revenue
FY16
COUR β
UTI $347M
FY17
COUR β
UTI $324M
FY18
COUR β
UTI $317M
FY19
COUR $184M
UTI $332M
FY20
COUR $294M
UTI $301M
FY21
COUR $415M
UTI $335M
FY22
COUR $524M
UTI $419M
FY23
COUR $636M
UTI $607M
FY24
COUR $695M
UTI $733M
FY25
COUR $758M
UTI $836M
COUR
UTI
Operating margin
FY16
COUR β
UTI β5.4%
FY17
COUR β
UTI β0.6%
FY18
COUR β
UTI β11.1%
FY19
COUR β26.2%
UTI β2.4%
FY20
COUR β22.7%
UTI β1.3%
FY21
COUR β34.5%
UTI 4.5%
FY22
COUR β33.9%
UTI 5.3%
FY23
COUR β22.9%
UTI 3.5%
FY24
COUR β16.3%
UTI 8.0%
FY25
COUR β10.2%
UTI 10.0%
COUR
UTI
Free cash flow
FY16
COUR β
UTI β$0.1M
FY17
COUR β
UTI β$7.0M
FY18
COUR β
UTI β$34.0M
FY19
COUR β$25.7M
UTI $15.3M
FY20
COUR β$18.1M
UTI $1.8M
FY21
COUR $0.2M
UTI β$6.1M
FY22
COUR β$39.6M
UTI β$33.4M
FY23
COUR $28.6M
UTI β$7.5M
FY24
COUR $93.8M
UTI $61.6M
FY25
COUR $107M
UTI $55.4M
COUR
UTI
Return on capital
FY16
COUR β
UTI β
FY17
COUR β
UTI β
FY18
COUR β
UTI β
FY19
COUR β
UTI β
FY20
COUR β
UTI β
FY21
COUR β
UTI 15.5%
FY22
COUR β
UTI 14.8%
FY23
COUR β
UTI 6.4%
FY24
COUR β
UTI 18.7%
FY25
COUR β
UTI 24.0%
COUR
UTI
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.